Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Wyeth Targeted "High Risk" Black Patients for Off-Label Kidney Drug Sales, Suit Claims
Wyeth Targeted "High Risk" Black Patients for Off-Label Kidney Drug Sales, Suit Claims
Wyeth Targeted "High Risk" Black Patients for Off-Label Kidney Drug Sales, Suit Claims
Submitted by
admin
on May 25, 2010 - 9:00am
Source:
BNET Pharma
News Tags:
Wyeth
Pfizer
lawsuits
off-label
Rapamune
Headline:
Wyeth Targeted "High Risk" Black Patients for Off-Label Kidney Drug Sales, Suit Claims
Do Not Allow Advertisers to Use My Personal information
